Plasmodium falciparum accounted for approximately 97% of malaria cases worldwide in 2023 and is highly endemic in sub-Saharan Africa. In 2023, P. vivax accounted for approximately 3.5% of the ...

Professor Markus Meißner from LMU Munich and Professor of Biochemistry Gernot Längst from the University of Regensburg led the study team, which found how PfSnf2L is essential for P. falciparum ...

P. falciparum usually presents within 1 month of exposure (minimum 6 days), although later presentations can occur. Other species may present over a year post-travel. Malaria in children can be ...

The R21/Matrix-M malaria vaccine, administered in four doses at 6, 7, 8 and 18 months, will initially target 1.1 million ...

The median age was 36.0 months in the subjects and 36.0 months in the controls, both groups were comparable (p > 0.05). Children between the ages of 1 to 5 years constituted 62.2% of the entire ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

All malaria rapid diagnostic tests have been implicated in the WHO product alert, as manufacturer investigations continue.

QIAGEN N.V. today announced the launch of the QIAprep&amp Plasmodium Kit and two companion assays to support malaria research and surveillance efforts. This new solution combines sample preparation ...

Genomics is the study of the full genetic complement of an organism (the genome). It employs recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyse the ...